Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vincristine-Topotecan-Cyclophosphamide in Localized Ewing Sarcoma
NCT00334867Phase 3Withdrawn
- Sponsor
- Children's Oncology Group
- Start
- Dec 2005
- Primary completion
- Jan 2006
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01
Overview
A Phase 3 trial of topotecan liposome in Ewing sarcoma, primitive neuroectodermal tumor (PNET), sponsored by Children's Oncology Group. Planned start Dec 2005; status: withdrawn.
02
Drugs
topotecan liposome
03
Conditions
Ewing sarcomaprimitive neuroectodermal tumor (PNET)
Beyond the preview
Go deeper on NCT00334867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00334867.